--Conversational agents, such as chatbots and virtual assistants, have become essential in software development, boosting productivity, collaboration, and automating various tasks. This paper examines the role of adaptive AI-powered conversational agents in software development, highlighting their ability to offer dynamic, context-aware assistance to developers. Unlike traditional rule-based systems, adaptive AI agents use machine learning and natural language processing to learn from interactions and improve over time, providing more personalized and responsive help. We look at how these tools have evolved from simple query-based systems to advanced AI-driven solutions like GitHub Copilot and Microsoft T eams bots. We also explore the challenges of integrating adaptive AI into software development processes. The study aims to assess the benefits and limitations of these systems, address concerns like data privacy and ethical issues, and offer insights into their future use in the field. Ultimately, adaptive AI chatbots have great potential to revolutionize software development by delivering real-time, customized support and enhancing the efficiency of development cycles. Conversational agents (CAs), including chatbots, dialogue systems, and virtual assistants, are software-based systems designed to process natural language and simulate intelligent dialogue with users [1].

Artificial Intelligence (AI) models deployed in production frequently face challenges in maintaining their performance in non-stationary environments. This issue is particularly noticeable in medical settings, where temporal dataset shifts often occur. These shifts arise when the distributions of training data differ from those of the data encountered during deployment over time. Further, new labeled data to continuously retrain AI is not typically available in a timely manner due to data access limitations. To address these challenges, we propose a proactive self-adaptive AI approach, or pro-adaptive, where we model the temporal trajectory of AI parameters, allowing us to short-term forecast parameter values. To this end, we use polynomial spline bases, within an extensible Functional Data Analysis framework. We validate our methodology with a logistic regression model addressing prior probability shift, covariate shift, and concept shift. This validation is conducted on both a controlled simulated dataset and a publicly available real-world COVID-19 dataset from Mexico, with various shifts occurring between 2020 and 2024. Our results indicate that this approach enhances the performance of AI against shifts compared to baseline stable models trained at different time distances from the present, without requiring updated training data. This work lays the foundation for pro-adaptive AI research against dynamic, non-stationary environments, being compatible with data protection, in resilient AI production environments for health.

Long gone are the days when AI was a futuristic concept that few companies had seriously considered embracing. According to a NewVantage Partners report, more than 91 percent of leading businesses say they have ongoing investments in AI. Corporate leaders also view AI as an essential tool, with 86 percent of CEOs reporting that AI is a mainstream technology in their organization. While traditional AI solutions continue to become a more commonplace tool used by enterprises, adaptive AI is rapidly turning into the next major innovation in the AI space. Unlike conventional AI systems that are not able to learn from interacting with new data they process, adaptive AI repeatedly learns from the data it encounters to improve itself.

Do you want to learn more about artificial intelligence? Consider adaptive AI, a revolutionary type of AI that can continuously learn and adapt to new situations and changes in its environment. Current use cases of adaptive AI are the commonly known self-driven cars and digital assistants, while the lesser-known examples are fraud detection and medical diagnosis. So, what does the future hold for adaptive AI? And what does it mean for individuals and industries?

Picture this: As a Covid-19 patient fights for her life on a ventilator, software powered by artificial intelligence analyzes her vital signs and sends her care providers drug-dosing recommendations -- even as the same software simultaneously analyzes in real time the vital signs of thousands of other ventilated patients across the country to learn more about how the dosage affects their care and automatically implements improvements to its drug-dosing algorithm. When an algorithm encounters a real-world clinical setting, adaptive AI might allow it to learn from these new data and incorporate clinician feedback to optimize its performance. Instead of being unleashed, artificial self-control lets a manufacturer put adaptive AI on a longer leash, allowing the algorithm to explore within a defined space to find the optimal operating point. When the algorithm is ready to incorporate what it has learned from real-world data about how drug-dosing information has affected other patients on ventilators, it first goes through a controlled revalidation process, automatically testing its performance on a random sample from a large representative test dataset in the cloud, a dataset that has been carefully curated by the manufacturer to ensure it is representative of the overall population and has high quality information about drug-dosing and patient outcomes. The test is logged, and each data point used in the test is carefully controlled to ensure that the algorithm is not simply getting better and better at predicting the answer in a small test set (a common problem in machine learning called overfitting) but is instead truly improving its performance.

Picture this: As a Covid-19 patient fights for her life on a ventilator, software powered by artificial intelligence analyzes her vital signs and sends her care providers drug-dosing recommendations -- even as the same software simultaneously analyzes in real time the vital signs of thousands of other ventilated patients across the country to learn more about how the dosage affects their care and automatically implements improvements to its drug-dosing algorithm. This type of AI has never been allowed by the Food and Drug Administration. But that day is coming. AI that continuously learns from new data and modifies itself, called adaptive AI, faces some steep barriers. All FDA-cleared or approved AI-based software is "locked," meaning the manufacturer cannot allow adaptations for real-world use without new testing to confirm that it still works properly.

Artificial intelligence can be various things: doing intelligent things with computers, or doing smart things with computers the manner in which individuals do them. Computers work uniquely in contrast to our brains: our minds are serial consciously, however, parallel underneath. Computers are serial underneath, however, we can have different processors, and there are now parallel hardware architectures too. All things considered, it's difficult to do parallel in parallel, though we're normally that way. Copying human methodologies has been a long-standing exertion in AI, as a mechanism to affirm our comprehension.

Artificial intelligence can be various things: doing intelligent things with computers, or doing smart things with computers the manner in which individuals do them. Computers work uniquely in contrast to our brains: our minds are serial consciously, however, parallel underneath. Computers are serial underneath, however, we can have different processors, and there are now parallel hardware architectures too. All things considered, it's difficult to do parallel in parallel, though we're normally that way. Copying human methodologies has been a long-standing exertion in AI, as a mechanism to affirm our comprehension.

Whether the objective is teaching behavior to kids, being an effective team member, or building more impenetrable cyber defenses, learning from a good example works. This is pertinent to artificial intelligence (AI) in finance, where enhanced forms like adaptive AI are fulfilling the technology's promise by actually "learning" -- foremost from the behavior of legitimate deposit account holders -- so that hackers stand out when they make a move. Emerging uses of adaptive AI and other new tech is set out in the new FI Fraud Decisioning Playbook, a PYMNTS and Simility collaboration, as financial institutions (FIs) and their clients ready for reopening by modeling good customer behavior to help identify bad actors. The inaugural FI Fraud Decisioning Report takes a keen interest in asymmetries between good customers and cyberthieves, as the two groups' data footprints are quite different. "Fraud decisioning strategies are more effective when the data gathered and analyzed includes high-quality evaluations of legitimate customers," the report states.

With the ever-evolving technological landscape, business needs and outcomes no longer exist as a default. Organizations across industries are adopting artificial intelligence (AI) systems to solve complex business problems, design intelligent and self-sustaining solutions and, essentially, stay competitive at all times. To this end, continued efforts are being made to reinvent AI systems so that more can be achieved with less. Adaptive AI is a key step in that direction. The reason why it could outpace traditional machine learning (ML) models in the near future is for its potential to empower businesses in achieving better outcomes while investing less time, effort and resources.